Product Information

PREMARIN 0.9 MG TABLET is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $6.9342 per EA under NDC 00046110381. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREMARIN 0.9 MG TABLET

estrogens, conjugated
$6.9342per EA

Strength

.9 mg/1

NDC

00046110381

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ESTROGENS, CONJUGATED

Approval Type

New Drug (NDA)

FDA Application

NDA004782

FDA Approved

Before 1982

TE Code

AB

On Market Since

1/1/2006

Pharmacological Classes

Estrogen Receptor Agonists
Estrogen
Estrogens
Conjugated (USP)

Price Statistics

The NADAC for PREMARIN 0.9 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has risen 148.4%. The table below summarizes its recorded NADAC range and movement.

Current price$6.9342 per EA
All-time high$6.9555 (Jun 10, 2026)
All-time low$2.7911 (Nov 28, 2013)
52-week high$6.9555
52-week low$6.7643
Median price$5.6827
Average price$5.4390
Largest weekly change+9.4% (Jun 11, 2014)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.0%

3M

-0.1%

6M

-0.3%

1Y

+2.5%

3Y

+8.4%

5Y

+16.8%

All

+148.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the estrogens, conjugated market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREMARIN 0.9 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PREMARIN 0.9 MG TABLET, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $6.9342 per EA (NDC 00046110381), effective Nov 11, 2026.

How has the price of PREMARIN 0.9 MG TABLET changed over time?

Over the history we have for it, the NADAC for PREMARIN 0.9 MG TABLET has risen 148.4%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PREMARIN 0.9 MG TABLET?

Since Nov 28, 2013, the NADAC for PREMARIN 0.9 MG TABLET has ranged from a low of $2.7911 (Nov 28, 2013) to a high of $6.9555 (Jun 10, 2026), with a median of $5.6827 per EA.

Are there cheaper alternatives to PREMARIN 0.9 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PREMARIN 0.9 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PREMARIN 0.9 MG TABLET?

PREMARIN 0.9 MG TABLET (NDC 00046110381) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.